News Story: Full Text
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website


Returning to work after multimodal treatment in glioblastoma patients

Al's Comment:

 This should be a key endpoint for clinical trials for glioblastomas.  In this study, only 18% of the patients went back to work after surgery, radiation and Temodar.  Out of these who did go back to work, most were not able to resume full time work. Only about 8 out of the 125 patients were able to return to work full time.    Some of the new experimental treatments such as DCVAX and Tocagen  not only had some long term survivors, but had people working full time in high level jobs 5+ years after diagnosis.  That is really what we want to see, even more than merely "surviving".

Posted on: 06/30/2018

Returning to work after multimodal treatment in glioblastoma patients


Click HERE to return to brain tumor news headlines

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557